doi: 10.1016/j.wneu.2023.10.086
Predicting anticancer peptides with Chous pseudo amino acid composition and investigating their mutagenicity via Ames test
Disclosures: Eveline Gart: Sagimet: Independent Contractor, Mead Johnson: Independent Contractor, Lars Verschuren: Nothing to Disclose, Anne Mak: Nothing to Disclose, Andre Boonstra: Gilead: Grant/Research Support, Janssen Pharma: Grant/Research Support, GSK: Grant/Research Support, Fujirebio: Grant/Research Support, Joanne Verheij: Nothing to Disclose, Lise Lotte Gluud: Nothing to Disclose, Adriaan Holleboom: Nothing to Disclose, Maarten Tushuizen: Nothing to Disclose 2044 EMPAGLIFLOZIN REDUCES LIVER FIBROSIS CAUSED BY CCL4: UNDERSTANDING THE MECHANISM Fushuang Ha 1 Tao Han 2 Junjun Cai 3 Junqing Yan 3 Yin Gu 4 , 1 The Third Central Hospital of Tianjin, 2 Tianjin Union Medical Center, Naikai University Affiliated Hospital, 3 Tianjin Third Central Hospital, 4 Tianjin NaiKai Hospital Background: Liver fibrosis is a reversible response to liver damage and inflammation caused by chronic factors
This gene codes for the MTHFR enzyme, a key enzyme in the methylation cycle
EuropeResearch links Cartalax to local cartilage processes rather than broad inflammatory signaling, which separates its role from peptides studied for wider inflammation effects
